These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 33428502)

  • 1. Multi-criteria decision analysis to prioritize the introduction of new vaccines in Indonesia by using the framework of the strategic multi-attribute ranking tool for vaccines (SMART vaccines).
    Suwantika AA; Purwadi FV; Zakiyah N; Puspitasari IM; Abdulah R; Diantini A; Boersma C; Postma MJ
    Expert Rev Vaccines; 2021 Jan; 20(1):83-91. PubMed ID: 33428502
    [No Abstract]   [Full Text] [Related]  

  • 2. Informing vaccine decision-making: A strategic multi-attribute ranking tool for vaccines-SMART Vaccines 2.0.
    Knobler S; Bok K; Gellin B
    Vaccine; 2017 Jan; 35 Suppl 1():A43-A45. PubMed ID: 28017435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What criteria do decision makers in Thailand use to set priorities for vaccine introduction?
    Pooripussarakul S; Riewpaiboon A; Bishai D; Muangchana C; Tantivess S
    BMC Public Health; 2016 Aug; 16():684. PubMed ID: 27484123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priority setting of vaccine introduction in Bangladesh: a multicriteria decision analysis study.
    Haider MS; Youngkong S; Thavorncharoensap M; Thokala P
    BMJ Open; 2022 Feb; 12(2):e054219. PubMed ID: 35228286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'It takes two to tango': Bridging the gap between country need and vaccine product innovation.
    Archer RA; Kapoor R; Isaranuwatchai W; Teerawattananon Y; Giersing B; Botwright S; Luttjeboer J; Hutubessy RCW
    PLoS One; 2020; 15(6):e0233950. PubMed ID: 32520934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination.
    Clark A; Jauregui B; Griffiths U; Janusz CB; Bolaños-Sierra B; Hajjeh R; Andrus JK; Sanderson C
    Vaccine; 2013 Jul; 31 Suppl 3():C19-29. PubMed ID: 23777686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimising the introduction of multiple childhood vaccines in Japan: A model proposing the introduction sequence achieving the highest health gains.
    Standaert B; Schecroun N; Ethgen O; Topachevskyi O; Morioka Y; Van Vlaenderen I
    Health Policy; 2017 Dec; 121(12):1303-1312. PubMed ID: 29079394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How Are New Vaccines Prioritized in Low-Income Countries? A Case Study of Human Papilloma Virus Vaccine and Pneumococcal Conjugate Vaccine in Uganda.
    Wallace L; Kapirir L
    Int J Health Policy Manag; 2017 Dec; 6(12):707-720. PubMed ID: 29172378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CAPACITI Decision-Support Tool for National Immunization Programs.
    Botwright S; Giersing BK; Meltzer MI; Kahn AL; Jit M; Baltussen R; El Omeiri N; Biey JN; Moore KL; Thokala P; Mwenda JM; Bertram M; Hutubessy RCW
    Value Health; 2021 Aug; 24(8):1150-1157. PubMed ID: 34372981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals - an application on improving tender decision making in Indonesia.
    Inotai A; Brixner D; Maniadakis N; Dwiprahasto I; Kristin E; Prabowo A; Yasmina A; Priohutomo S; Németh B; Wijaya K; Kalo Z
    BMC Health Serv Res; 2018 Dec; 18(1):1003. PubMed ID: 30594250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Religious and community leaders' acceptance of rotavirus vaccine introduction in Yogyakarta, Indonesia: a qualitative study.
    Padmawati RS; Heywood A; Sitaresmi MN; Atthobari J; MacIntyre CR; Soenarto Y; Seale H
    BMC Public Health; 2019 Apr; 19(1):368. PubMed ID: 30943929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prioritization of the introduction of new vaccines to the national immunization program in the Republic of Korea.
    Choe YJ; Han OP; Cho H; Bae GR; Chun BC; Kim JH; Kim KH; Lee HJ; Choi EH
    Vaccine; 2014 Oct; 32(46):6049-53. PubMed ID: 25239482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of Japanese encephalitis (JE) immunization in Bali, Indonesia.
    Liu W; Clemens JD; Kari K; Xu ZY
    Vaccine; 2008 Aug; 26(35):4456-60. PubMed ID: 18602436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the economic impact of pneumococcal conjugate, Haemophilus influenzae type b and rotavirus vaccines in India: National and state-level analyses.
    Constenla D; Liu T
    Vaccine; 2019 Dec; 37(52):7547-7559. PubMed ID: 31607600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC.
    Debellut F; Jaber S; Bouzya Y; Sabbah J; Barham M; Abu-Awwad F; Hjaija D; Ramlawi A; Pecenka C; Clark A; Mvundura M
    PLoS One; 2020; 15(2):e0228506. PubMed ID: 32023295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact and cost effectiveness of pneumococcal conjugate vaccine in India.
    Krishnamoorthy Y; Eliyas SK; Nair NP; Sakthivel M; Sarveswaran G; Chinnakali P
    Vaccine; 2019 Jan; 37(4):623-630. PubMed ID: 30587430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategic Planning in Population Health and Public Health Practice: A Call to Action for Higher Education.
    Phelps C; Madhavan G; Rappuoli R; Levin S; Shortliffe E; Colwell R
    Milbank Q; 2016 Mar; 94(1):109-25. PubMed ID: 26994711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The decision making process on new vaccines introduction in South Africa.
    Ngcobo NJ; Cameron NA
    Vaccine; 2012 Sep; 30 Suppl 3():C9-13. PubMed ID: 22939028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer prevention in Indonesia: An updated clinical impact, cost-effectiveness and budget impact analysis.
    Setiawan D; Andrijono ; Hadinegoro SR; Meyta H; Sitohang RV; Tandy G; Perwitasari DA; Postma MJ
    PLoS One; 2020; 15(3):e0230359. PubMed ID: 32203527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of introducing universal childhood rotavirus vaccination in Bangladesh.
    Sarker AR; Sultana M; Mahumud RA; Van Der Meer R; Morton A
    Hum Vaccin Immunother; 2018 Jan; 14(1):189-198. PubMed ID: 29099653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.